Structured evidence table for Melissa Anxiety Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Melissa Anxiety Randomized Trial | The VOLTAIRE trial aims to assess the impact of providing personalized cardiovascular risk information derived from computed tomography coronary angiography (CTCA) and a polygenic risk score (PRS) on cardiovascular risk factor modification. | 4 | Chen R (2026) | Evaluation of Polygenic Scores and CT Imaging in Risk Factor Modification in Patients With Diabetes: Rationale and Design of the VOLTAIRE Study. |
| Melissa Anxiety Randomized Trial | Objectives VOLTAIRE evaluates whether integrating CTCA and PRS into risk counseling enhances adherence to lifestyle and pharmacological interventions, ultimately improving cardiovascular outcomes among patients with T2D. | 4 | Chen R (2026) | Evaluation of Polygenic Scores and CT Imaging in Risk Factor Modification in Patients With Diabetes: Rationale and Design of the VOLTAIRE Study. |
| Melissa Anxiety Randomized Trial | Participants are randomized 1:1:1 to receive: (1) risk factor counseling plus CTCA result, (2) risk factor counseling plus PRS result, or (3) standard risk factor counseling (control). | 4 | Chen R (2026) | Evaluation of Polygenic Scores and CT Imaging in Risk Factor Modification in Patients With Diabetes: Rationale and Design of the VOLTAIRE Study. |
| Melissa Anxiety Randomized Trial | Background The contemporary management of type 2 diabetes (T2D) involves a multifaceted model of care integrating intensive management of lipids, blood pressure, and glucose, along with lifestyle modifications. | 4 | Chen R (2026) | Evaluation of Polygenic Scores and CT Imaging in Risk Factor Modification in Patients With Diabetes: Rationale and Design of the VOLTAIRE Study. |
| Melissa Anxiety Randomized Trial | Historical use of medicinal plants was a result of cumulative trial and error experience and the transmission of traditional knowledge between generations, which later inspired systematic efforts to turn empirical claims into evidence-based arguments []. | 4 | Cîmpeanu Ioan-Alexandru (2026) | Melissa officinalis L. (Lemon Balm): An Integrative Review of Phytochemistry and Evidence from Preclinical Research to Clinical Studies |
| Melissa Anxiety Randomized Trial | Also, standardization and phytochemical reporting is the preferred method for interpreting the evidence base across Lamiaceae, as its composition is influenced by genetics, geography, cultivation, and post-harvest handling [,]. | 4 | Cîmpeanu Ioan-Alexandru (2026) | Melissa officinalis L. (Lemon Balm): An Integrative Review of Phytochemistry and Evidence from Preclinical Research to Clinical Studies |
| Melissa Anxiety Randomized Trial | Accordingly, the present review mapsfrom botanical and phytochemical fundamentals through recent preclinical advances and available clinical evidence, with emphasis on endpoints that best support translation and reproducibility across study types. | 4 | Cîmpeanu Ioan-Alexandru (2026) | Melissa officinalis L. (Lemon Balm): An Integrative Review of Phytochemistry and Evidence from Preclinical Research to Clinical Studies |
| Melissa Anxiety Randomized Trial | 1 2 2 1 3 4 1 2 4 5 Traditional healing systems and contemporary natural products research still depend on medicinal and aromatic plants, which continue to provide structurally diverse bioactive compounds with broad therapeutic potential [,]. | 4 | Cîmpeanu Ioan-Alexandru (2026) | Melissa officinalis L. (Lemon Balm): An Integrative Review of Phytochemistry and Evidence from Preclinical Research to Clinical Studies |
Source documents